Russia’s Sputnik V Vaccine: 97.6% Effectiveness

According to the Gamaleya Institute in Moscow and the Russian Direct Investment Fund, the Sputnik V vaccine is 97.6% effective against COVID-19 in a “real-world” evaluation based on data from 3.8 million citizens.

The current effectiveness rate is higher than the 91.6 percent rate recorded in results from a large-scale trial of Sputnik V published earlier this year in The Lancet medical journal, and it correlates favorably with data on the effectiveness of other COVID-19 vaccines.

The latest figures are focused on 3.8 million Russians who got both a first and a booster shot as part of Sputnik V’s nationwide rollout.The frequency of infection was estimated from the 35th day after the first injection, with a rate of 0.027 percent, according to the statement.

The information was gathered from the health ministry’s database of people who have been vaccinated, as well as a separate database of people who have been infected with COVID-19 in the region, according to the release.It stated that the rate of infection among unvaccinated adults was 1.1 percent for a period of time following the start of mass vaccination in Russia, without specifying the time period.

“This data confirms that Sputnik V demonstrates one of the best protection rates against coronavirus among all vaccines,” said Kirill Dmitriev, the head of the RDIF sovereign wealth fund, which is funding the vaccine.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button